Option chain shows key data for Azitra's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Azitra.

Azitra (AMEX:AZTR) Stock, Option Chain

Anitra

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

5 Stocks To Watch Heading Into Thursday

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AZTR

OMGA

QNTM

VLCN

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Palantir,Technologies,Japan,Logo,,Tokyo,,Japan,2024,Sep.15

Pre-Market Outlook

Movers

AREB

BCTX

EVAX

HCWB

ILMN

IVVD

KAPA

PDLB

PLTR

REBN

TNXP

UOKA

XPEV

ZONE

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

JPMorgan Chase.photoShutterstock

ACON

COMP

KROS

SGBX

VMAR

Crude Oil Rises Sharply; JPMorgan Chase Earnings Top Views

Azitra Inc

Press Releases

Azitra to Present at BIO-Europe 2024

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra, Inc. to Present at Biotech Showcase 2025 Alongside the J.P. Morgan Annual Healthcare Conference

Offerings

Azitra Announces Proposed Public Offering of Common Stock

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra, Inc. to Present at The Microcap Conference

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra to Present at Microbiome Times Partnering Forum

Aditxt

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Aptevo Therapeutics

180 Life Sciences

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

GT Biopharma

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mustang Bio

NuCana

Oragenics

Plus Therapeutics

Sunshine Biopharma

SILO Pharma

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Comments

Azitra

Azitra (AZTR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga